Coronavirus (COVID-19)

Advice for people with diabetes and their families

Save for later

Diabetes UK grant awardees and success rates

Diabetes UK Success Rates

We are excited to share, for the first time, our research funding outcomes and success rates over the last 10 years (PDF).

2018 Awards

Every year, Diabetes UK funds exceptional research with the potential to change lives of people with diabetes. Here you can see the list of our 2018 grant awardees.


Sir George Alberti Training Fellowships

  • Investigating Safety Signals and Real-World Effectiveness in Sodium-Glucose Co-Transporter-2 Inhibitors – A Big Data Study
    Dr Thomas Caparrotta, University of Edinburgh
  • Exploring the metabolic impact of mild autonomous cortisol excess (MACE), an underestimated cause of diabetes
    Dr Alessandro Prete, University of Birmingham

RD Lawrence Fellowships

  • Adult onset Type 1 Diabetes: Are Slow Progressors and Late Starters examples of immune regulators?
    Dr Anna Long, University of Bristol
  • Elucidating the role of gut hormones in infertility associated with diabetes, obesity and PCOS
    Dr RC Moffett, University of Ulster

PhD Studentships

  • Targeting beta-cell failure in lean patients with type 2 diabetes
    Professor Sven Plein, University of Leeds
  • Insulin receptor phosphorylation of SNARE proteins at the plasma membrane
    Professor Gwyn Gould, University of Glasgow
  • The role of heterotypic cell-to-cell communication in mediating inflammation and fibrosis in the diabetic kidney
    Professor Paul Squires, University of Lincoln
  • Pancreatic beta-cell autophagy and its regulation by glucose metabolism
    Dr Catherine Arden, University of Newcastle
  • Utilising spider venom peptides for diabetes drug discovery
    Dr Nigel Irwin, University of Ulster 
  • Clinical and cellular characterisation of beta cell transcription factor variants in people with young-onset diabetes from different ethnicities
    Professor Guy Rutter, Imperial College London
  • Using novel AMP-activated protein kinase activators for restoration of the glucagon response to hypoglycaemia in diabetes
    Dr Craig Beall, University of Exeter Medical School
  • Using genetics to improve the prediction of large for gestational age babies in women with gestational diabetes
    Dr Rachel Freathy, University of Exeter

2018 Project awards

  • B cell chemotaxis in Type 1 diabetes mellitus
    Professor F. Susan Wong, Cardiff University
  • Using genetics to improve the prediction of large for gestational age babies in women with gestational diabetes
    Dr Rachel Freathy, University of Exeter
  • Immunomodulation of type I diabetes by pharmacologically-enhanced delivery of regulatory T cells
    Professor Federica Marelli-Berg, Queen Mary University of London
  • 2-HDP: a novel therapeutic for diabetic retinopathy
    Professor Tim M Curtis, Queen's University Belfast
  • How does insulin resistance increase risk of Alzheimer's disease?
    Dr Amritpal Mudher, University of Southampton
  • Thymic B cells; aggressors in Type 1 diabetes
    Dr Allison Green, University of York
  • Heparan sulphate in the glomerular endothelial glycocalyx: importance in diabetes and potential as a therapeutic target
    Dr Simon Satchell, University of Bristol
  • Development of tools to investigate the role of DNA structures in diabetes
    Dr Zoe Waller, University of East Anglia
  • An open-label, multi-centre, randomised, parallel design study to assess the efficacy of flash glucose monitoring in adults with Type 1 diabetes
    Dr Lalantha Leelarathna, University of Manchester    
  • Sx16 phosphorylation as a regulatory mechanism controlling insulin-stimulated glucose transport
    Professor Gwyn Gould, University of Glasgow    
  • The role of LRG1 in diabetic retinopathy
    Professor Stephen Moss, University College London, Institute of Opthalmology
  • The Impact of Type 2 Diabetes on Cardiac Metabolic Phenotype in Patients with Severe Aortic Stenosis
    Professor Sven Plein, University of Leeds    
  • Fine-tuning islet NAD levels to prevent beta-cell de-differentiation in Type 2 diabetes
    Dr Paul Caton, Kings College London
  • Exploiting CaSR-mediated vagal signalling to treat Type 2 diabetes
    Professor Kevin Murphy, Imperial College London
  • Investigating the long-term relationship between cardiovascular and metabolic factors and the risk of dementia in people with Type 2 diabetes
    Dr Eszter Vamos, Imperial College London
  • Affimers targeting multiple anti-fibrinolytic proteins for the management of the enhanced thrombotic environment in diabetes
    Dr Ramzi Ajjan
  • New treatments for severe Type 2 diabetes in lipodystrophy
    Dr Justin Rochford, University of Aberdeen
  • C5aR, a novel immunomodulator of metabolic signalling and energy metabolism in skeletal muscle
    Dr Hari Hundal, University of Dundee 

Early-Career Small Grants

  • Interactions between gut microbiota in type 2 diabetes and beneficial wholegrain polyphenols with subsequent impact on pancreatic islet function
    Dr Astrid Hauge Evans, University of Roehampton
  • Deciphering the crosstalk between miRNAs and m6A RNA modifications in hyperglycaemic endothelial cells
    Dr Aranzazu Chamorro Jorganes, Imperial College London 
  • Using state-of-the-art genetic technologies to identify low-level mosaic mutations and provide new diagnoses in monogenic diabetes
    Dr Matthew Johnson, University of Exeter Medical School
  • Seated exercise intervention to improve cardio-respiratory fitness, physical function, metabolic health and quality of life in diabetic foot patients
    Dr Matthew McCarthy, University of Leicester
  • Repurposing rosuvastatin for the prevention of hypoglycaemia in diabetes
    Dr Craig Beall, University of Exeter Medical School
  • Investigating the effects of hyperglycaemia and environmental chemical exposure on mitochondrial DNA
    Dr Katherine Chapman, Swansea University
Brand Icons/Telephone check - FontAwesome icons/tick icons/uk